2020
DOI: 10.1590/s0004-2803.202000000-08 View full text |Buy / Rent full text
|
|

Abstract: BACKGROUND: Hepatitis C virus (HCV) infection is the most common hepatotropic viral infection affecting the patients on maintenance hemodialysis. Treatment of chronic HCV infection in stage 4 and 5 CKD includes a combination of elbasvir/grazoprevir and glecaprevir/pibrentasvir, which are not available in many countries. OBJECTIVE: Hence, we have conducted this study to look for the safety and efficacy of sofosbuvir combination therapy in this difficult to treat population. METHODS: We conducted a single-c… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
10
0

Publication Types

Select...

Relationship

0
0

Authors

Journals